We report a 13-year-old female with rapid-onset obesity, hypothalamic dysfunction, hypoventilation, and autonomic dysregulation (ROHHAD) syndrome, panhypopituitarism, dyslipidemia, type 2 diabetes mellitus, and nonalcoholic fatty liver disease, who developed rhabdomyolysis and acute kidney injury, two weeks after switching from lovastatin to rosuvastatin. She had been on lovastatin for eight years without any adverse effects.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jacl.2021.09.002 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The Enigma That Is ROHHAD Syndrome: Challenges and Future Strategies.
Brain Sci
October 2024
Bristol Royal Hospital for Children, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol BS2 8BJ, UK.
Rapid-onset obesity with hypoventilation, hypothalamic dysfunction, and autonomic dysregulation (ROHHAD) is a rare syndrome presenting in early childhood associated with a high risk of mortality between 50 and 60%. It is characterised by rapid, early onset of obesity between 1.5-7 years, along with central hypoventilation and hypothalamic dysfunction, such as central hypothyroidism, hyperprolactinemia, disorders of sodium and water balance, growth hormone deficiency, adrenocortical insufficiency, or disorders of puberty and features of autonomic dysregulation.
View Article and Find Full Text PDFLong Term Ventilation in Pediatric Central Apnea: Etiologies and Therapeutic Approach over a Decade.
Pediatr Pulmonol
January 2025
Pediatric Pulmonology and Respiratory Intermediate Care Unit, Sleep and Long-Term Ventilation Unit, Academic Department of Pediatrics, Pediatric Hospital "Bambino Gesù" Research Institute, Rome, Italy.
Objective: This retrospective study aimed to analyze the clinical characteristics, ventilatory strategies, and effectiveness of ventilation in pediatric patients with central apneas treated at the Sleep Medicine and Long-Term Ventilation Unit of the Bambino Gesù Children's Hospital in Rome from 2012 to 2022.
Methods: Among all ventilated patients at our Center from January 2012 to December 2022, we retrospectively included children with a cAHI ≥ 1 events/h on baseline poly(somno)graphic study. Additional parameters assessed included the underlying disease, type of ventilation (non-invasive vs.
Case Report: A case of thoracoscopic mediastinal tumor resection in a child with ROHHAD syndrome.
Front Pediatr
September 2024
Department of Anesthesiology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Article Synopsis
- ROHHAD syndrome is a rare condition marked by rapid obesity, hypothalamic and autonomic dysfunction, and respiratory issues, making it complex to manage.
- This case report describes a child with ROHHAD who required surgery due to a mediastinal tumor, highlighting surgical challenges like hypernatremia and airway concerns.
- Anesthesiologists must be aware of the unique aspects of ROHHAD to ensure safe anesthesia management, tailoring their approach to each child's specific needs.
Management of obesity in an individual with ROHHAD syndrome with semaglutide 2.4 mg/week: a case report.
Clin Auton Res
September 2024
Nutrition-Diabetes Department, University Hospital of Montpellier, 191 Avenue du Doyen Gaston Giraud, 34295, Montpellier, France.
An autopsy case of an adult woman with Rapid-Onset Obesity with Hypoventilation, Hypothalamic, Autonomic Dysregulation, and Neuroendocrine Tumors (ROHHAD(NET)) syndrome developing nonalcoholic steatohepatitis and hepatocellular carcinoma: A case report.
Medicine (Baltimore)
May 2024
Faculty of Medicine, Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Miyazaki, Miyazaki, Japan.
Article Synopsis
- Nonalcoholic steatohepatitis (NASH) can lead to hepatocellular carcinoma (HCC), yet there are no established treatments, and a rare syndrome known as ROHHAD(NET) can complicate this condition.
- The case study details the oldest known autopsy of a patient with ROHHAD(NET) who developed HCC, providing insights into the syndrome's progression and its relationship with NASH and HCC.
- The patient experienced rapid obesity and other severe symptoms since childhood, was diagnosed with cirrhosis at 17 and HCC at 20, underwent treatment, but ultimately died from complications at age 21, with autopsy findings revealing significant necrosis of the cancer.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!